Clinical Trials Logo

Filter by:
NCT ID: NCT05939167 Recruiting - AIDS Clinical Trials

Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage

Start date: December 10, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

The goal of this study is to conduct a prospective, double-blind, randomized placebo-controlled clinical trial to investigate the safety and efficacy of mesenchymal stem cells treatment for AIDS patients at late stage.

NCT ID: NCT05939154 Not yet recruiting - Mental Disorder Clinical Trials

Early Identification of Mental Disorders: Application of a Multi-modal & Domains System

Start date: August 1, 2023
Phase:
Study type: Observational

This study aims to build a multi-modal collection template and establish a multi-modal database of seven mental disorders including depressive disorders, bipolar disorders, schizophrenia, obsessive-compulsive disorder, anxiety disorders, addictive disorders and sleep-wake disorders by collecting voice information, facial micro-expression, eye tracking, EEG physiology data respectively. This study will contribute to the multi-modal diagnosis of major mental disorders such as depression in the future and realize clinical application.

NCT ID: NCT05939063 Recruiting - Clinical trials for Left-sided Pancreatic Cancer

LRAMPS Versus LDP in Selected Early-stage Left-sided Pancreatic Cancer

Start date: October 1, 2023
Phase: N/A
Study type: Interventional

This multicenter randomized controlled clinical trial proposed the criteria for selecting patients with early-stage left-sided pancreatic cancer and aimed to compare the perioperative and oncological outcomes of patients within the criteria who underwent laparoscopic radical antegrade modular pancreatosplenectomy versus laparoscopic distal pancreatosplenectomy.

NCT ID: NCT05938920 Active, not recruiting - Clinical trials for Idiopathic Pulmonary Fibrosis (IPF)

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis (IPF)

Start date: June 19, 2023
Phase: Phase 2
Study type: Interventional

The goal of this clinical trial is to learn about INS018_055 in adults with Idiopathic Pulmonary Fibrosis (IPF). The primary objective is to evaluate the safety and tolerability of INS018_055 orally administered for up to 12 weeks in adult subjects with IPF compared to placebo.

NCT ID: NCT05938907 Recruiting - Bone Substitute Clinical Trials

Effect of Concentrated Growth Factors on Healing of Apicomarginal Defects: a Prospective Study

Start date: June 15, 2023
Phase: N/A
Study type: Interventional

The persistent and chronic apical periodontitis has caused great difficulties for clinical physicians. Ensuring rapid and successful healing of the extensively damaged periapical region is a pressing issue that needs to be addressed. The treatment options include traditional apical surgery, simultaneous placement of bone powder and membrane after apical surgery, and simultaneous placement of sticky bone (bone powder mixed with concentrated growth factors gel) and membrane. However, high-quality evidence regarding these various treatment options is scarce. The purpose of this study is to compare the advantages and disadvantages of each treatment option, in order to guide clinical physicians in the application of apical surgery.

NCT ID: NCT05938881 Recruiting - Clinical trials for Pelvic Organ Prolapse

Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study

Start date: June 29, 2023
Phase:
Study type: Observational

The original RCT trial is designed to compare self-tailored titanium-coated polypropylene mesh procedure with mesh-kit in the treatment of POP stage III-IV in terms of efficacy, safety and cost-effective at 1-year follow-up. This study will follow women in the original RCT study for up to 10 years from the time of the surgery to compare success and complication rates in the two groups. Recruitment into this study is open only to women that already participated in previous RCT, no new treatment interventions will be given. Recruitment into the previous RCT is closed. Women will be strongly encouraged to participate in annual examinations and annual telephone surveys but may participate in only one of these study parts if needed.

NCT ID: NCT05938374 Recruiting - Soft Tissue Sarcoma Clinical Trials

Preoperative Moderately Fractionated IMRT for Locally Extremity or Trunk Sarcoma

Start date: May 1, 2023
Phase: Phase 2
Study type: Interventional

To investigate the safety and efficacy of preoperative moderately fractionated IMRT and concurrent Fluzoparib Hydrochloride for primary truncal or extremity soft tissue sarcoma.

NCT ID: NCT05938348 Completed - Postoperative Pain Clinical Trials

Pain Relief Effect of Angiopuncture for Patients With Postoperative Pain

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The study aimed to investigate the effectiveness of angiopuncture therapy in pain alleviation for postoperative pain patients. The study involved patients aged 20-65 with acute foot and ankle trauma and pain after surgery. Physicians used handheld ultrasound Doppler to measure perforators, puncture participants with a filiform needle, and monitor pain scores and heart rate data before and after acupuncture. The duration of therapy was 20 minutes per day for 72 hours, with pain measured using the numerical rating scale. The study aimed to compare the outcomes before and after angiopuncture.

NCT ID: NCT05938309 Recruiting - Clinical trials for Gastrointestinal Stromal Tumors

A Cohort Study on the Safety of Laparoscopic Resection of 5cm or Larger Gastric Gastrointestinal Stromal Tumors

Start date: May 1, 2023
Phase:
Study type: Observational

The purpose of this study is to explore the safety of laparoscopic resection of 5cm or larger gastric gastrointestinal stromal tumors

NCT ID: NCT05938231 Completed - Obesity Clinical Trials

Tangji Gastric Bypass Stent Study for Obesity

Start date: March 15, 2021
Phase: N/A
Study type: Interventional

The Gastric Bypass Stent System is intended to be used in weight loss treatment for obesity in patients with a BMI ≥ 30 kg/m2. In this clinical investigation the Sponsor seeks to demonstrate the safety and performance of the Gastric Bypass Stent System for its proposed indication in weight loss treatment for obesity in the China.